Analysis Article • Aug 08
Have your own idea? Try our Stock Screener
Indian (NIFTY) Pharma Industry Analysis
UpdatedAug 11, 2026
DataAggregated Company Financials
Companies181
- 7D0.4%
- 3M11.4%
- 1Y18.3%
- YTD18.0%
Last week, the Pharma industry hasn't moved much but Aurobindo Pharma is up 6.0% in that time. The past year has been better, since the industry has gained 18% in that time. Earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 11 Aug 2026 | ₹24.3t | ₹4.6t | ₹655.9b | 30.3x | 37.1x | 5.3x |
| Thu, 09 Jul 2026 | ₹23.5t | ₹4.5t | ₹643.3b | 29.8x | 36.5x | 5.3x |
| Sat, 06 Jun 2026 | ₹22.1t | ₹4.5t | ₹643.0b | 28.9x | 34.3x | 4.9x |
| Mon, 04 May 2026 | ₹21.0t | ₹4.4t | ₹619.9b | 29x | 33.9x | 4.8x |
| Wed, 01 Apr 2026 | ₹19.8t | ₹4.3t | ₹621.3b | 24.5x | 31.9x | 4.6x |
| Fri, 27 Feb 2026 | ₹20.7t | ₹4.3t | ₹621.1b | 26.7x | 33.4x | 4.8x |
| Sun, 25 Jan 2026 | ₹19.5t | ₹4.2t | ₹604.9b | 29.1x | 32.2x | 4.6x |
| Tue, 23 Dec 2025 | ₹20.6t | ₹4.2t | ₹614.5b | 28.9x | 33.5x | 4.9x |
| Thu, 20 Nov 2025 | ₹20.4t | ₹4.2t | ₹611.2b | 29.7x | 33.5x | 4.9x |
| Sat, 18 Oct 2025 | ₹20.3t | ₹4.1t | ₹589.5b | 30.6x | 34.4x | 5x |
| Mon, 15 Sep 2025 | ₹20.6t | ₹4.1t | ₹589.1b | 31.5x | 35x | 5.1x |
| Wed, 13 Aug 2025 | ₹20.0t | ₹4.1t | ₹592.4b | 31.2x | 33.8x | 4.9x |
| Fri, 11 Jul 2025 | ₹20.4t | ₹4.0t | ₹594.1b | 32.6x | 34.3x | 5.1x |
| Sun, 08 Jun 2025 | ₹20.2t | ₹4.0t | ₹595.3b | 32x | 33.9x | 5.1x |
| Tue, 06 May 2025 | ₹19.7t | ₹3.9t | ₹563.0b | 29.8x | 35x | 5.1x |
| Thu, 03 Apr 2025 | ₹19.2t | ₹3.9t | ₹559.4b | 29.5x | 34.4x | 4.9x |
| Sat, 01 Mar 2025 | ₹18.0t | ₹3.9t | ₹561.5b | 25.8x | 32.1x | 4.6x |
| Mon, 27 Jan 2025 | ₹19.9t | ₹3.8t | ₹531.6b | 31.6x | 37.5x | 5.2x |
| Wed, 25 Dec 2024 | ₹20.8t | ₹3.8t | ₹526.7b | 34.8x | 39.4x | 5.5x |
| Fri, 22 Nov 2024 | ₹20.1t | ₹3.8t | ₹526.7b | 31.6x | 38.1x | 5.3x |
| Sun, 20 Oct 2024 | ₹21.4t | ₹3.7t | ₹492.6b | 40.1x | 43.4x | 5.7x |
| Tue, 17 Sep 2024 | ₹21.7t | ₹3.7t | ₹492.6b | 42.6x | 44.1x | 5.8x |
| Thu, 15 Aug 2024 | ₹20.2t | ₹3.8t | ₹489.0b | 35x | 41.4x | 5.4x |
| Sat, 13 Jul 2024 | ₹18.6t | ₹3.6t | ₹449.9b | 35x | 41.4x | 5.2x |
| Mon, 10 Jun 2024 | ₹17.4t | ₹3.6t | ₹448.1b | 32.7x | 38.8x | 4.9x |
| Wed, 08 May 2024 | ₹16.9t | ₹3.5t | ₹420.1b | 34.3x | 40.1x | 4.8x |
| Fri, 05 Apr 2024 | ₹17.1t | ₹3.5t | ₹418.9b | 33.5x | 40.9x | 4.9x |
| Sun, 03 Mar 2024 | ₹16.9t | ₹3.5t | ₹418.7b | 33.2x | 40.4x | 4.9x |
| Tue, 30 Jan 2024 | ₹15.9t | ₹3.4t | ₹396.1b | 34.8x | 40.2x | 4.7x |
| Thu, 28 Dec 2023 | ₹14.8t | ₹3.4t | ₹395.2b | 32.8x | 37.5x | 4.4x |
| Sat, 25 Nov 2023 | ₹14.0t | ₹3.4t | ₹395.1b | 31x | 35.6x | 4.2x |
| Mon, 23 Oct 2023 | ₹13.1t | ₹3.3t | ₹368.0b | 29.8x | 35.6x | 4x |
| Wed, 20 Sep 2023 | ₹13.3t | ₹3.3t | ₹369.5b | 30.3x | 35.9x | 4.1x |
| Fri, 18 Aug 2023 | ₹13.1t | ₹3.3t | ₹367.0b | 28.7x | 35.6x | 4x |
Price to Earnings Ratio
35.6x
Current Industry PE
- Investors are relatively neutral on the Indian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 36.6x.
- The industry is trading close to its 3-year average PS ratio of 4.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 21% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 0.11% | |
| Healthcare | 0.35% | |
| Pharma | 0.40% | |
| Pharma | 0.40% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ZYDUSLIFE Zydus Lifesciences | ₹1.19k | 5.4% +₹60.8b | 24.6% | PE23.6x | |
| GLAND Gland Pharma | ₹2.92k | 13.2% +₹56.2b | 51.3% | PE42.7x | |
| 524558 Neuland Laboratories | ₹22.95k | 19.0% +₹47.0b | 76.5% | PE59.2x | |
| AUROPHARMA Aurobindo Pharma | ₹1.66k | 4.5% +₹41.5b | 56.7% | PE25.7x | |
| 500124 Dr. Reddy's Laboratories | ₹1.21k | 3.8% +₹36.9b | -1.3% | PE30.3x |
